For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Joslin Diabetes Center, Inc.

Calculating rank

USPTO Granted Patents = 76

% Expired Patents = 35.5

EPO Patents = 11

Trademarks = 3

Forward Citations = 975

Loading Chart...

Loading Chart...

92 inventors (with patents filed for the assignee):

C Ronald Kahn (16 out of 16 patents)

Yu-Hua Tseng (10 out of 10 patents)

George Liang King (8 out of 11 patents)

4. Steven E Shoelson (6 out of 7 patents)

5. Matthew Lynes (4 out of 4 patents)

6. Andrzej Krolewski (4 out of 5 patents)

7. Lloyd Paul Aiello (4 out of 5 patents)

8. Morris F White (4 out of 4 patents)

9. Monika A Niewczas (3 out of 3 patents)

10. Eleftheria Maratos-Flier (3 out of 4 patents)

11. Atul J Butte (3 out of 8 patents)

12. Arun Sharma (3 out of 3 patents)

13. Mary Elizabeth Patti (3 out of 3 patents)

14. Allison B Goldfine (3 out of 3 patents)

15. Wanzhu Jin (3 out of 3 patents)

Core Competencies:

Glucose Tolerance

Beta Cell Protection

Micro-RNAs

Metabolic Disorders

Diabetic Complications

Adipocyte Function

Renal Disease

Immunotherapy

Angiogenesis

Insulin Sensitivity

Thermogenic Potential

Retinal Imaging

76 patents: Sort by Forward Citations

1. 12583916 - Methods to improve glucose tolerance in a subject by administering an antibody that binds to extracellular human metallothionein 1A (MT1A) (2026-03-24),

2. 12559746 - Targeting Micro-RNAs for Exosomal Delivery or Cellular Retention (2026-02-24),

3. 12545895 - Protection of Beta Cells from Immune Attack (2026-02-10),

4. 12161463 - Prevention of post-bariatric hypoglycemia using a novel glucose prediction algorithm and mini-dose stable glucagon (2024-12-10),

5. 12005039 - Methods and compositions relating to lipokines for treating metabolic disorders (2024-06-11),

6. 11885813 - Methods of diagnosing and predicting renal disease (2024-01-30),

7. 11866488 - Compositions comprising an anti-metallothionein antibody and a pancreatic cell targeting moiety (2024-01-09),

8. 11708561 - Protection of beta cells from immune attack (2023-07-25),

9. 11519008 - Exosome delivery system (2022-12-06),

10. 11433042 - Methods and compositions for treating metabolic disorders (2022-09-06),

11. 11078259 - Methods and compositions for promoting thermogenic potential (2021-08-03),

12. 11059880 - Redirected cells with MHC chimeric receptors and methods of use in immunotherapy (2021-07-13),

13. 10716836 - Methods for treating autoimmune disease by inducing autoantigen-specific regulatory CD4+ T cells (2020-07-21),

14. 10632175 - Exercise-regulated adipokines as therapy for diabetes management (2020-04-28),

15. 10488420 - Methods of diagnosing and predicting renal disease (2019-11-26),

Company Overview

Joslin Diabetes Center, Inc., based in Boston, MA, is a leading institution dedicated to diabetes management and research. The center specializes in advancing knowledge and treatment of diabetes through innovative research in areas such as glucose tolerance, beta cell protection, and metabolic disorders. Joslin's work encompasses critical topics including diabetic complications, adipocyte function, renal disease, and immunotherapy, positioning it at the forefront of diabetes care and research on a global scale.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

76 Patents

#34 in Boston, MA

#270 in Massachusetts

#4,851 in US

#9,904 in the World

Boston, MA, United States of America

Joslin Diabetes Center, Inc.

Forward Citations = 975

92 inventors:

C Ronald Kahn (16 out of 16 patents)

Yu-Hua Tseng (10 out of 10 patents)

George Liang King (8 out of 11 patents)

4. Steven E Shoelson (6 out of 7 patents)

5. Matthew Lynes (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Joslin Diabetes Center, Inc.. Retrieved from https://idiyas.com/company/joslin-diabetes-center

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…